Low-Intensity Electrical Pulses Enhance Immune Response Against Cancer
Recent research from Virginia Tech's Fralin Biomedical Research Institute suggests that applying low-intensity electrical pulses can alter the tumor environment in ways that make cancer more vulnerable to the body's immune defenses. Unlike high-intensity pulses that directly destroy tumors, these milder electrical stimuli do not kill cancer cells outright but instead modify blood vessel and lymphatic network growth within and around the tumor. Notably, blood vessel density increases within a day, and lymphatic vessels grow by the third day post-treatment, potentially guiding immune cells more effectively toward the tumor.
Published in the nns of Biomedical Engineering, the study investigates a lower-intensity form of high-frequency irreversible electroporation (H-FIRE). While traditional H-FIRE eradicates tumor tissue by applying electrical pulses, this sub-ablative technique focuses on remodeling the tumor microenvironment, paving the way for enhanced immune detection and attack.
The researchers utilized a mouse model of breast cancer to examine vascular changes post-treatment. They observed that this approach induces beneficial remodeling of blood and lymphatic vessels, which may boost the immune response. Specifically, the increased signals within these vessels are thought to direct immune cells more effectively toward the tumor, potentially making subsequent treatments more successful.
Jennifer Munson, the study's lead author, emphasized that these vascular changes could be pivotal in improving cancer therapies when combined with existing treatments. Further research aims to explore how this remodeling influences immune activity and the possibility of integrating electrical pulse therapies with other immunotherapies to enhance overall effectiveness.
This groundbreaking work expands understanding of how low-intensity electrical pulses can indirectly help the immune system combat cancer, offering a new avenue for less invasive and more targeted treatment strategies.
Source: https://medicalxpress.com/news/2025-04-intensity-electrical-pulses-immune-cancer.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Drug Candidate Targets Lung Cancer Growth While Sparing Healthy Cells
A groundbreaking study introduces AVJ16, a targeted molecule that inhibits lung cancer growth by blocking a key protein, sparing healthy tissue. This promising preclinical research paves the way for personalized and precise cancer therapies.
New Insights into Protein Complexes Responsible for Neuron Death in Alzheimer’s Disease
Researchers have identified a neurotoxic protein complex that promotes nerve cell death in Alzheimer’s disease. Using innovative compounds, they demonstrated potential for slowing disease progression by targeting this complex, offering new hope for neurodegenerative therapies.
How Kidney Organoids Enhance Safety in Gene Therapy Trials
Human kidney organoids are emerging as vital tools to detect hidden risks in gene therapy, potentially preventing adverse effects and enhancing treatment safety before clinical use.
Innovative AI-Driven, Affordable Blood Tests for Early Alzheimer’s Detection
A team of scientists at the University of Liverpool has developed low-cost, AI-powered blood tests capable of detecting early signs of Alzheimer's disease, promising broader access to early diagnosis and treatment.